Zhengye Biotechnology Holding Ltd (ZYBT) › Cash & EquivalentsZhengye Biotechnology Holding Ltd (ZYBT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2023: 15.07M CNY2024: 18.60M CNY18.60M CNY2023Cash & Equivalents (CNY)2024Fiscal YearCash & EquivalentsChange YoY202418.60M CNY+23.4%202315.07M CNY—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share